15 completed, 2 recruiting. 7 Not applicable, 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 6, Recruiting 1 |
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow Meddoc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Long-term Effect of Daily Jarlsberg Cheese Intake in Patient With Osteopenia Jarlsberg cheese - Osteopenia, Osteoporosis | Not applicable | Completed | Meddoc | 20 | 2024-06-03 | 2025-05-09 |
| Validation of Bulbicam Used on Patient Suffering From Diabetes Without Retinopathy Bulbicam - Diabetes | Completed | Meddoc | 32 | 2024-06-03 | 2025-05-15 | |
| Profylactic Treatment for Patients in Risk Osteoporosis Calsium, Vitamin D, Jarlsberg cheese - Osteopenia or Osteoporosis | Not applicable | Recruiting | Meddoc | 60 | 2023-05-02 | 2025-09-29 |
| Efficacy Comparison of Jarlsberg- and Norvegia Cheese on Bone Markers and Bone Mineral Density in Nordic Skiers Jarlsberg cheese, Norvegia - Bone Health, Performance Enhancing Product Use | Not applicable | Completed | Meddoc | 60 | 2023-04-17 | 2024-11-18 |
| Recommended Dose Estimation of BP-C2 BP-C2 - Prostate Cancer | Phase 1 | Recruiting | Meddoc | 8 | 2023-04-01 | 2025-05-09 |
| Daily Dose Estimation of Jarlsberg Cheese in Healthy Norwegian Elderly Male and Female Jarlsberg cheese - Healthy Aging | Not applicable | Completed | Meddoc | 30 | 2023-01-19 | 2024-05-22 |
| Bulbicam Validation on Glaucoma- and Cataract Patients Bulbicam - Glaucoma Eye, Cataract | Completed | Meddoc | 64 | 2023-01-10 | 2024-05-22 | |
| Validation of Bulbicam for DR- and AMD-patients BulbiCam - Diabetic Retinopathy, Age-Related Macular Degeneration | Completed | Meddoc | 64 | 2022-12-19 | 2024-05-22 | |
| Validation of Bulbicam for Parkinson- and Ataxia-patients BulbiCam - Parkinson Disease, Ataxia | Completed | Meddoc | 64 | 2022-12-19 | 2024-05-22 | |
| Dose Estimation of Jarlsberg Cheese in Young, Active Norwegian Cross-country Skiers (XCS) Jarlsberg cheese - Healthy Nutrition | Not applicable | Completed | Meddoc | 20 | 2021-05-11 | 2022-07-07 |
| Estimation of a Maintaining Daily Jarlsberg Cheese-dose Jarlsberg Cheese - Maintenance Dose, Osteocalcin | Not applicable | Completed | Meddoc | 12 | 2020-01-16 | 2022-06-30 |
| Response Surface Pathway Design With Two Interventional- and One Response Variable in Estimating Minimum Efficacy Dose Osteopatic Manual Therapy (OMT) - GERD | Not applicable | Completed | Meddoc | 15 | 2016-09-28 | 2018-06-26 |
| BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer BP-C1, BP-C2 - Metastatic Pancreatic Cancer, Unresectable Pancreatic Cancer | Phase 2 | Completed | Meabco A/S | 16 | 2014-12-19 | 2018-11-15 |
| BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer BP-C1, Placebo - Metastatic Breast Cancer, Stage IV Breast Cancer | Phase 2 | Completed | Meabco A/S | 38 | 2014-06-05 | 2019-10-07 |
| BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment BP-C1 - Metastatic Breast Cancer, Stage IV Breast Cancer | Phase 2 | Completed | Meabco A/S | 29 | 2013-02-22 | 2019-10-10 |
| BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer BP-C1, Placebo - Metastatic Breast Cancer, Stage IV Breast Cancer | Phase 2 | Completed | Meabco A/S | 36 | 2012-12-24 | 2019-10-10 |
| Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer BP-C1 - Metastatic Breast Cancer, Stage IV Breast Cancer | Phase 1 | Completed | Meabco A/S | 18 | 2009-06-27 | 2020-03-06 |
Breast Neoplasms (4) · Bone Diseases, Metabolic (2) · Osteoporosis (2) · Ataxia (1) · Cataract (1) · Diabetes Mellitus (1) · Diabetic Retinopathy (1) · Gastroesophageal Reflux (1) · Macular Degeneration (1) · Pancreatic Neoplasms (1) · Parkinson Disease (1) · Prostatic Neoplasms (1) · Vitamin K Deficiency (1)
Norway (11) · Thailand (4) · Russia (2) · Egypt (1) · Indonesia (1) · Taiwan (1)
Goran Petrovski, PhD (3) · Stig E Larsen, PhD (3) · Anne C Whist, PhD (2) · Emilia Kerty, PhD (1) · Helge E Lundberg, MD (1) · Henning Arboe (1) · Kritiya Butthongkomvong, MD (1) · Svein Aa Ingelholm, PhD (1) · Tarek Ibrahim, MD (1)
PMID 25473312, PMID 25792808, PMID 26170717, PMID 30666153, PMID 41025612, PMID 41180014, PMID 42853286